Penn Virginia Corp. (PVA) Jumps 25.03% on December 23

Equities Staff |

Penn Virginia Corp. (PVA) was among the biggest gainers on the Russell 2000 for Wednesday December 23 as the stock popped 25.03% to $0.37, representing a gain of $0.074 per share. Some 3.02 million shares traded hands on 3,651 trades, compared with an average daily volume of 2.52 million shares out of a total float of 73.36 million. The stock opened at $0.30 and traded with an intraday range of $0.37 to $0.29.

After today's gains, Penn Virginia Corp. reached a market cap of $27.12 million. Penn Virginia Corp. has had a trading range between $8.03 and $0.26 over the last year, and it had a 50-day SMA of $0.58 and a 200-day SMA of $2.98.

Penn Virginia Corp is an independent oil and gas company. The Company is engaged in the exploration, development and production of crude oil, natural gas liquids and natural gas in onshore regions of the United States.

Penn Virginia Corp. is based out of Radnor, PA and has some 164 employees. Its CEO is Edward B. Cloues.

For a complete fundamental analysis analysis of Penn Virginia Corp., check out Equities.com’s Stock Valuation Analysis report for PVA. To see the latest independent stock recommendations from Equities.com’s analysts, visit our Research section.

The Russell 2000 is one of the leading indices tracking small-cap companies in the United States. It's maintained by Russell Investments, an industry leader in creating and maintaining indices, and consists of the smallest 2000 stocks from the broader Russell 3000 index.

Russell's indices differ from traditional indices like the Dow Jones Industrial Average (DJIA) or S&P 500, whose members are selected by committee, because they base membership entirely on an objective, rules based methodology. The 3,000 largest companies by market cap make up the Russell 3000, with the 2,000 smaller companies making up the Russell 2000. It's a simple approach that gives a broad, unbiased look at the small-cap market as a whole.

For more news on the financial markets, go to Equities.com. Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Comments

Emerging Growth

Veritas Pharma Inc.

Veritas Pharma Inc, formerly Seashore Organic Medicine Inc is an emerging producer and distributor of medical marijuana.

Private Markets

Lyft

Lyft matches drivers using their own personal vehicles with passengers who request rides through the smartphone app, and the passengers pay automatically through the app. When using Lyft, passengers have…

BioSculpture Technology, Inc.

BioSculpture Technology, Inc. (“BST”) is a commercial-stage medical device manufacturer of liposuction surgical instruments for surgeons. It offers the FDA-cleared Twin Cannula Assisted Liposuction ("TCAL") Airbrush Liposculptor II® controllers, Airbrush®…